Company Filing History:
Years Active: 2004-2007
Title: Dmitry Pruss: Pioneering Genetic Research in Salt Lake City
Introduction
Dmitry Pruss, an innovative inventor based in Salt Lake City, UT, has made significant strides in the field of genetics. With a total of three patents to his name, Pruss focuses on identifying genetic variants that predispose individuals to cancer, particularly breast and ovarian cancers.
Latest Patents
Among his latest patents is a groundbreaking discovery titled "Large deletions in human BRCA1 gene and use thereof." This research reveals that large deletions in the BRCA1 gene can increase the risk of breast and ovarian cancer. The methods developed by Pruss are aimed at detecting these genetic variants, offering crucial insights into cancer predisposition. Additionally, he has patented a methodology under the name "Method of identifying genomic rearrangements." This patent provides a framework for detecting large genomic rearrangements using unphased genotype data. The approach allows for the comparison of unphased genotypes at multiple nucleotide variant markers, revealing the likelihood of genomic rearrangements in diploid subjects.
Career Highlights
Dmitry Pruss currently holds a position at Myriad Genetics, Inc., a company recognized for its contributions to genetic testing and analysis. His work here focuses on advancing the understanding of genetic predispositions to serious health conditions, which can significantly impact patient care and treatment options.
Collaborations
Throughout his career, Pruss has collaborated with several esteemed colleagues, including Thomas M. Scholl and Brant C. Hendrickson. These partnerships have further enhanced his research and have been instrumental in the development of his innovative patents.
Conclusion
Dmitry Pruss stands out as a prominent figure in genetic research, particularly in the fields of cancer predisposition and genomic rearrangement detection. His contributions through patents and collaboration with leading experts underscore his dedication to advancing knowledge in genetics and improving health outcomes for patients.